Ali, F., Kedwany, A. M., Nawab, A., Khalid, A., Tariq, S. (2026). Aumolertinib as first-line therapy for locally advanced or metastatic
                    <i>EGFR</i>
                    -mutant non–small cell lung cancer: A single-arm meta-analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20715